MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

CCEL — Cryo-Cell International Inc.

NYSE American

Cryo-Cell International Inc.

CompareBack to Screener
$3.99
-0.06(-1.48%)
O
4.11
H
4.11
L
3.99
V
1.49K
⏱️ End-of-day dataAs of Oct 2, 2026
OverviewStatisticsFinancialsHistorical DataOptionsDividend HistoryNewsChart

Cryo-Cell International Inc. Statistics

Total Valuation

Market Cap$34.19M
Enterprise Value$34.19M

Important Dates

Earnings Daten/a
Ex-Dividend Daten/a

Share Statistics

Current Share Classn/a
Shares Outstanding8.06M
Shares Change (YoY)n/a
Shares Change (QoQ)n/a
Owned by Insiders (%)n/a
Owned by Institutions (%)n/a
Floatn/a

Valuation Ratios

PE Ratio57.00
Forward PEn/a
PS Ration/a
Forward PSn/a
PB Ration/a
P/TBV Ration/a
P/FCF Ratio18,855.84
P/OCF Ratio22,041.03
PEG Ration/a

Enterprise Valuation

EV / Earnings61,609.86
EV / Salesn/a
EV / EBITDA22,189.14
EV / EBIT26,923.99
EV / FCF18,860.16

Financial Position

Current Ratio0.71
Quick Ration/a
Debt / Equity-0.47
Debt / EBITDA5.41
Debt / FCF4.60
Interest Coveragen/a

Financial Efficiency

Return on Equity (ROE)-3.13%
Return on Assets (ROA)0.91%
Return on Invested Capital (ROIC)n/a
Return on Capital Employed (ROCE)n/a
Weighted Average Cost of Capital (WACC)n/a
Revenue Per Employeen/a
Profits Per Employee$7
Employee Count76
Asset Turnovern/a
Inventory Turnovern/a

Taxes

Income Tax$273
Effective Tax Raten/a

Stock Price Statistics

Beta (5Y)n/a
52-Week Price Change-11.92%
50-Day Moving Average$3.97
200-Day Moving Average$3.59
Relative Strength Index (RSI)42.76
Average Volume (20 Days)13,972

Short Selling Information

Short Interestn/a
Short Previous Monthn/a
Short % of Shares Outn/a
Short % of Floatn/a
Short Ratio (days to cover)n/a

Income Statement

Revenuen/a
Gross Profit$6.10K
Operating Income$1.20K
Pretax Income$828
Net Income$555
EBITDA$1.54K
EBIT$1.27K
Earnings Per Share$0.07

Balance Sheet

Cash & Cash Equivalents$507
Total Debt$8.34K
Net Cash-$7.84K
Net Cash Per Share$-0.00
Equity (Book Value)-$17.76K
Book Value Per Share$-0.00
Working Capital-$4.63K

Cash Flow

Operating Cash Flow$1.55K
Capital Expenditures-$-33
Depreciation & Amortizationn/a
Net Borrowingn/a
Free Cash Flow$1.81K
FCF Per Share$0.00

Margins

Gross Marginn/a
Operating Marginn/a
Pretax Marginn/a
Profit Marginn/a
EBITDA Marginn/a
EBIT Marginn/a
FCF Marginn/a

Dividends & Yields

Dividend Per Sharen/a
Dividend Yieldn/a
Dividend Growth (YoY)n/a
Years of Dividend Growthn/a
Payout Ration/a
Buyback Yieldn/a
Shareholder Yieldn/a
Earnings Yield1.75%
FCF Yield0.01%

Analyst Forecast

Price Targetn/a
Price Target Differencen/a
Analyst Consensusn/a
Analyst Countn/a
Revenue Growth Forecast (3Y)n/a
EPS Growth Forecast (3Y)n/a

Fair Value

Lynch Fair Value$1.05
Lynch Upside-73.68%
Graham Numbern/a
Graham Upsiden/a

Stock Splits

Last Split Daten/a
Split Typen/a
Split Ration/a

Scores

Altman Z-Scoren/a
Piotroski F-Scoren/a